Cardiovascular risk in rheumatoid arthritis – evaluation and treatment

1. Gabriel, S.E. (2008). Why do persons with rheumatoid arthritis still die prematurely? Ann. Rheum. Dis. 67 (Suppl 3), iii30-iii34. DOI: 10.1136/ard.2008.098038.10.1136/ard.2008.098038283086119022810Search in Google Scholar

2. Wallberg-Jonsson, S., Johansson, H. & Ohman, M.L. (1999). Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J. Rheumatol. 26(12), 2562-2571.Search in Google Scholar

3. Graham, I., Atar, D. & Borch-Johnsen, K. (2007). European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur. J. Cardiovasc. Prev. Rehabil. 14(Suppl 2), E1-40. DOI: 10.1097/01. hjr.0000277984.31558.c410.1097/01Search in Google Scholar

4. Peters, M.J., Symmons, D.P. & McCarey, D. (2010). EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann. Rheum. Dis. 69(2), 325-331. DOI: 10.1136/ ard.2009.113696.10.1136/ard.2009.11369619773290Search in Google Scholar

5. Kotseva, K., Wood, D. & De Backer, G. (2010). EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: crosssectional survey in 12 European countries. Eur. J. Cardiovasc. Prev. Rehabil. 17(5), 530-540. DOI: 10.1097/HJR.0b013e3283383f30.10.1097/HJR.0b013e3283383f3020577089Search in Google Scholar

6. Kremers, H.M., Bidaut-Russell, M. & Scott, C.G. (2003). Preventive medical services among patients with rheumatoid arthritis. J. Rheumatol. 30(9), 1940-1947.Search in Google Scholar

7. Toms, T.E., Panoulas, V.F. & Douglas, K.M. (2010). Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann. Rheum. Dis. 69(4), 683-688. DOI: 10.1136/ard.2009.115717.10.1136/ard.2009.11571719854705Search in Google Scholar

8. Arnett, F.C., Edworthy, S.M. & Bloch, D.A. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31(3), 315-324.10.1002/art.17803103023358796Search in Google Scholar

9. Conroy, RM., Pyorala, K. & Fitzgerald, AP. (2003). On behalf of the SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. EuropeanHeart Journal. 24(11), 987-1003. DOI: 10.1016/ S0195-668X(03)00114-3Search in Google Scholar

10. Mancia, G., Laurent, S. & Agabiti-Rosei, E. (2009). Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press. 18(6), 308-347. DOI: 10.3109/0803705090345046810.3109/0803705090345046820001654Search in Google Scholar

11. Dorobantu, M., Badila, E. & Darabont, R. (2006). Studiul SEPHAR-Studiu de prevalență a hipertensiunii arteriale și evaluare a riscului cardiovascular în România. Rev. Rom. Cardiol. XXI(2), 179-189.Search in Google Scholar

12. Banegas, JR., Lopez-Garcia, E. & Dallongeville, J. (2011). Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur. Heart J. 32(17), 2143-2152. DOI: 10.1093/eurheartj/ehr080.10.1093/eurheartj/ehr080316410321471134Search in Google Scholar

13. Dorobantu, M., Badila, E. & Ghiorghe, S. (2008). Total cardiovascular risk estimation in Romania. Data from the SEPHAR study. Rom. J. Intern. Med 46(1), 29-37.Search in Google Scholar

14. Bunescu, D.M., Stoffers, H.E. & van den Akker, M.J. (2008). Coronary heart disease and cardiovascular risk factors among people aged 25-65 years, as seen in Romanian primary healthcare. Eur. J. Gen. Pract. 14(2), 56-64. DOI: 10.1080/13814780802343141.10.1080/1381478080234314118720274Search in Google Scholar

15. Semb, A.G., Kvien, T.K. & DeMicco, D.A. (2012) Effects of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease. Arthritis Rheum. 64(9), 2836-2846. DOI: 10.1002/art.34524.10.1002/art.3452422576673Search in Google Scholar

16. Toms, T.E., Smith, J.P. & Panoulas, V.F. (2010). Prevalence of risk factors for statin-induced myopathy in rheumatoid arthritis patients. Musculoskeletal Care. 8(1), 2-9. DOI: 10.1002/ msc.160.10.1002/msc.16019642078Search in Google Scholar

17. De Vera, M.A., Choi, H. & Abrahamowicz, M. (2011). Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study. Ann. Rheum. Dis. 70(6), 1020-1024. DOI: 10.1136/ ard.2010.142455.10.1136/ard.2010.14245521378405Search in Google Scholar

18. Lindhardsen, J., Ahlehoff, O. & Gislason, G.H. (2012). Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study. Ann. Rheum. Dis. 71(9), 1496-501. DOI: 10.1136/annrheumdis-2011-200806.10.1136/annrheumdis-2011-20080622402144Search in Google Scholar